GAO says FDA is too lax on DTC ads policing

Share this article:
The Government Accountability Office ripped the FDA for lax policing of DTC advertising, saying the agency was slow to act on dubious drug ads due to inconsistent standards and bureaucratic snafus. “We believe that regulatory letters should be issued more quickly,” said the GAO's report.

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.